Braxia Scientific Corp C.BRAX

Success and Expansion!!

[newcoin]

“Today’s announcement is the first of what we intend to be a series of growth developments and acquisitions to our clinical network,” said Braxia CEO Dr. Roger McIntyre. “Further plans are in place for the expansion of Braxia Health clinics in Toronto and Ottawa, Ont., to better serve the growing unmet need in our Canadian communities.” 

With Braxia’s ongoing Phase 2 multi-dose psilocybin trial in treatment resistant depression reporting positive preliminary results, and in response to demand amidst the evolving health-care dynamic resulting from the COVID-19 pandemic, leading to an increase in annual referrals, the Company will also be adding capacity at its new flagship centre in Toronto and its clinic in Ottawa.

Kevin Kratiuk, Braxia’s Vice-President of Operations, added, “While Braxia has been managing the patient volumes to date and ensuring care is delivered in a timely manner, an infrastructure expansion was needed to better support our communities and address the unmet burden of treatment-resistant depression. With our new clinic and future expansion plans for our existing clinics, we will also offer more convenient access to treatment for new and existing patients.”